We identified Cenpo, Mpp1 and Tbc1d10c which were genes also dysregulated in our previous human transcriptome data (Belzeaux et al., 2012; already validated from the classical threshold method selection) and identified three additional candidates: Fused in sarcoma (Fus), Immunoglobulin mu binding protein 2 (Ighmbp2), and Nucleotide binding protein 1 (Nubp1) for validation (Supplementary Table S6A, bold genes). This evidence concerns the gene FUS and sarcoma.